Prudential Financial’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $383K | Buy |
112,667
+6,285
| +6% | +$21.4K | ﹤0.01% | 2032 |
|
|
2025
Q1 | $427K | Sell |
106,382
-67,000
| -39% | -$269K | ﹤0.01% | 1891 |
|
|
2024
Q4 | $1.13M | Buy |
173,382
+63,600
| +58% | +$413K | ﹤0.01% | 1530 |
|
|
2024
Q3 | $608K | Buy |
109,782
+6,700
| +6% | +$37.1K | ﹤0.01% | 2132 |
|
|
2024
Q2 | $575K | Sell |
103,082
-9,150
| -8% | -$51.1K | ﹤0.01% | 2108 |
|
|
2024
Q1 | $753K | Sell |
112,232
-1,345
| -1% | -$9.03K | ﹤0.01% | 1974 |
|
|
2023
Q4 | $1.04M | Sell |
113,577
-2,610
| -2% | -$23.8K | ﹤0.01% | 1801 |
|
|
2023
Q3 | $641K | Buy |
116,187
+16,000
| +16% | +$88.3K | ﹤0.01% | 1964 |
|
|
2023
Q2 | $856K | Buy |
+100,187
| New | +$856K | ﹤0.01% | 1884 |
|